1 insider bought €33k of shares over the last 90 days, the latest by 강종구, filed 26 Oct 2026.
Biotoxtech Co., Ltd.: what insiders have been doing
Every trade that managers of Biotoxtech Co., Ltd. disclose to DART (FSS) is tracked on this page. The company sits in the Health Care sector. From 31 October 2025 to 31 October 2026, the disclosure feed for Biotoxtech Co., Ltd. logged 19 filings by 6 insiders.
Every open-market trade in the period is a purchase: 17 purchases, from 5 insiders, and not a single sale. No amount is published for 17 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Among those who bought: 4 board members, 1 senior executive and 1 chief executive.
For context, the typical company on the same exchange (median of 2,655 companies) published 7 filings over the same period, against 19 filings here. Over the whole record (from 2021), the tally stands at 34 purchases and 1 sale.
The most recent open-market purchase was published on 26 October 2026, 13 days ago. Between a trade and the moment it shows up on DART (FSS), the median delay is 3 days. This delay matters because a trade only becomes useful information once it is public.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and UCB. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Who traded when
BuySaleSince the insiders bought
- -24.0%Entry ₩2,630 · Close 30 Oct 2026 ₩1,999
- -24.0%Entry ₩2,630 · Close 30 Oct 2026 ₩1,999
- -23.6%Entry ₩2,615 · Close 30 Oct 2026 ₩1,999
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- 980 sharesShareKRXDART:20261026000221Canonical exit: 24 Jan 2027 (T+90)
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- 6,380 sharesShareKRXDART:20260901000053Canonical exit: 30 Nov 2026 (T+90)
- 13,865 sharesShareKRXDART:20260831000130Canonical exit: 29 Nov 2026 (T+90)
- Other0DART
- Other0DART
- Other0DART
- 10,094 sharesShareKRXDART:20260806000127Canonical exit: 4 Nov 2026 (T+90)
- Other0DART
- 738 sharesShareKRXDART:20260803000038Canonical exit: 1 Nov 2026 (T+90)
- Other0DART
- 4,305 sharesShareKRXDART:20260729000115Canonical exit: 27 Oct 2026 (T+90)
- Other0DART
- ●Executives0DART
- 0KRXDART:20260306000695
- 19,802 sharesKRXDART:20260209000105Canonical exit: 6 May 2026 (T+90)
- 19,802 sharesShareKRXDART:20260209000114Canonical exit: 10 May 2026 (T+90)
- 3,662 sharesShareKRXDART:20260122000054Canonical exit: 22 Apr 2026 (T+90)
- 22,581 sharesKRXDART:20260122000059Canonical exit: 19 Apr 2026 (T+90)
- 18,919 sharesShareKRXDART:20260121000159Canonical exit: 21 Apr 2026 (T+90)
25 of 57 declarations
About Biotoxtech Co., Ltd.
BioToxTech is a company in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions for the diagnosis and treatment of diseases.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
